Vitalhub (VHI) Stock Price, News & Analysis

Company Overview

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions. Vitalhub Corp. was founded in 2010 and is based in Toronto, Canada.

Key Stats

• Today's Range: C$11.07 to C$11.25
• 50-Day Range: C$9.67 to C$11.86
• 52-Week Range: C$6.74 to C$12.34
• Volume: 50,628 shs
• Average Volume: 127,598 shs
• Market Capitalization: C$603.13 million
• P/E Ratio: 181.35
• Dividend Yield: N/A
• Price Target: C$13.25
• Consensus Rating: Buy

Vitalhub Stock Analysis - MarketRank™

Vitalhub scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Buy

Consensus Rating

Vitalhub has received a consensus rating of Buy. The company's average rating score is 3.14, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Vitalhub has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Vitalhub is 181.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.62.

Price to Earnings Ratio vs. Sector

The P/E ratio of Vitalhub is 181.35, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 25.80.

Price to Earnings Growth Ratio

Vitalhub has a PEG Ratio of 1.18. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Vitalhub has a P/B Ratio of 4.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for VHI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Vitalhub does not currently pay a dividend.

Dividend Growth

Vitalhub does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for VHI.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.66

News Sentiment

Vitalhub has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Vitalhub this week, compared to 1 article on an average week.

Search Interest

1 people have searched for VHI on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Vitalhub to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Vitalhub insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$255,750.00 in company stock and sold C$0.00 in company stock.

Percentage Held by Insiders

18.57% of the stock of Vitalhub is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 32.40% of the stock of Vitalhub is held by institutions.

VHI Stock Analysis - Frequently Asked Questions

How have VHI shares performed this year?

Vitalhub's stock was trading at C$11.27 at the beginning of 2025. Since then, VHI stock has decreased by 1.1% and is now trading at C$11.15.
View the best growth stocks for 2025 here.

How do I buy shares of Vitalhub?

Shares of VHI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Vitalhub own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vitalhub investors own include AST SpaceMobile (ASTS), Intel (INTC), Tempus AI (TEM), Recursion Pharmaceuticals (RXRX), Advanced Micro Devices (AMD), Broadcom (AVGO) and Genius Sports (GENI).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Chemicals
• Current Symbol: TSE:VHI
• CIK: N/A
• Web: vitalhub.com
• Phone: 416-699-0123
• Fax: N/A
• Employees: 2,250
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$13.25
• High Stock Price Target: C$14.50
• Low Stock Price Target: C$10.50
• Potential Upside/Downside: +18.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.14
• Research Coverage: 7 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C$0.06
• Trailing P/E Ratio: 181.35
• Forward P/E Ratio: 48.55
• P/E Growth: 1.18
• Net Income: C$3.35 million
• Net Margins: 5.11%
• Pretax Margin: N/A
• Return on Equity: 3.01%
• Return on Assets: 3.81%

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 2.33
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$65.49 million
• Price / Sales: 9.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$2.53 per share
• Price / Book: 4.41

Miscellaneous

• Outstanding Shares: 54,092,368
• Free Float: N/A
• Market Cap: C$603.13 million
• Optionable: Not Optionable
• Beta: 1.26